Rhon-klinikum Ag · XETR:RHK
Rhon-klinikum — FY2015 Earnings Presentation
11 slides from Rhon-klinikum's earnings presentation, Feb 26, 2016
Slide 1: Preliminary Results for FY 2015
RHÖN-KLINIKUM AG Preliminary Results for FY 2015 February 26, 2016 Jens-Peter Neumann, CFO Dr. Kai G. Klinger
Slide 2: Disclaimer
Disclaimer This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for use during this presentation. It must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose
Slide 3: Highlights FY 2015
Highlights FY 2015 Return to smooth seas – reliability, profitability, growth June – AGM gave broad approval for (re-)election of supervisory board and dividend increase to € 0.80 per share August – acquisition of Kreisklinik Bad Neustadt Sept/Oct – successful execution of €167m share repurcha
Slide 4: Preliminary Results FY 2015
Preliminary Results FY 2015 * Delivered as First full year under new structure was successfully completed .. promised Group revenues € 1.11bn Group EBITDA € 154m Group net profit € 87m .. with reliable organic growth in a challenging environment… Volumes +1.5% (DRG case-mix-points) and +12.9
Slide 5: FY 2016 Outlook and General Assumptions
FY 2016 Outlook and General Assumptions Expected average Organic DRG growth still Expected input price First-time consolidation organic growth penalized by regulation inflation Kreisklinik Bad Neu- stadt (sales € +34m)** & KEY DRIVERS +3.0% to +4.0% p.a. ASSUMPTIONS 25% discount on agreed Wage
Slide 6: Breakdown of Main Extraordinary Effects on FY 2016 EBITDA
Breakdown of Main Extraordinary Effects on FY 2016 EBITDA 155m to 2016 will still be influenced by compensatory one-off items 165m A > +35m lapse of contractual risk from Fresenius/Helios SPA and mandatory release of underlying reserves B > -8m cost burden due to deferred settlement of UKGM’s separa
Slide 7: Marburg as Key for Future Prosperity of UKGM
Marburg as Key for Future Prosperity of UKGM Establish high-end medical outpatient clinic at Marburg Goal: double outpatient cases and significantly improve share of high-CMI inpatient cases Extend current outpatient facilities and build-up new outpatient and diagnostic center (capex ~ € 40m ove
Slide 8: Digitization Disrupts Traditional Healthcare Pattern
Digitization Disrupts Traditional Healthcare Pattern Set-up of new venture structure for eHealth and network medicine Minority stakes of up to 30% in young start-up companies from Europe and the U.S. (up to € 2.5m per single investment) Invest approx. 1-3 years after founding, when initial proof
Slide 9: Appendix – Financial Calendar
Appendix – Financial Calendar FY 2016 February 26, 2016 Preliminary results for financial year 2015 April 15, 2016 Press conference: publication of annual financial report 2015 May 6, 2016 Publication of interim report for the quarter ending March 31, 2016 June 8, 2016 Annual General Meeting
Slide 10: Appendix – Price Regulation at a Glance
Appendix – Price Regulation at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) Layer 1 DRG inflation in 2016: +2.95
Slide 11: Appendix – Shareholder Base
Appendix – Shareholder Base Like-for-like shareholder structure after capital reduction in 2015 as of 31 December 2015, according to the most recent notifications of voting rights at that time 19.8%2) B. Braun 50.30% 49.70% 47.1%1) Strategic Free Float Investors 17.6% Asklepios 6.9%2) Eugen Münch 3.